Literature DB >> 19893304

Auditory perception in individuals with Friedreich's ataxia.

Gary Rance1, Louise Corben, Elizabeth Barker, Peter Carew, Donella Chisari, Meghan Rogers, Richard Dowell, Saiful Jamaluddin, Rochelle Bryson, Martin B Delatycki.   

Abstract

INTRODUCTION: Friedreich's ataxia (FRDA) is an inherited ataxia with a range of progressive features including axonal degeneration of sensory nerves. The aim of this study was to investigate auditory perception in affected individuals.
METHODS: Fourteen subjects with genetically defined FRDA participated. Two control groups, one consisting of healthy, normally hearing individuals and another comprised of subjects with sensorineural hearing loss, were also assessed. Auditory processing was evaluated using structured tasks designed to reveal the listeners' ability to perceive temporal and spectral cues. Findings were then correlated with open-set speech understanding.
RESULTS: Nine of 14 individuals with FRDA showed evidence of auditory processing disorder. Gap and amplitude modulation detection levels in these subjects were significantly elevated, indicating impaired encoding of rapid signal changes. Electrophysiologic findings (auditory brainstem response, ABR) also reflected disrupted neural activity. Speech understanding was significantly affected in these listeners and the degree of disruption was related to temporal processing ability. Speech analyses indicated that timing cues (notably consonant voice onset time and vowel duration) were most affected.
CONCLUSION: The results suggest that auditory pathway abnormality is a relatively common consequence of FRDA. Regular auditory evaluation should therefore be part of the management regime for all affected individuals. This assessment should include both ABR testing, which can provide insights into the degree to which auditory neural activity is disrupted, and some functional measure of hearing capacity such as speech perception assessment, which can quantify the disorder and provide a basis for intervention. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19893304     DOI: 10.1159/000255341

Source DB:  PubMed          Journal:  Audiol Neurootol        ISSN: 1420-3030            Impact factor:   1.854


  17 in total

1.  A novel deletion-insertion mutation identified in exon 3 of FXN in two siblings with a severe Friedreich ataxia phenotype.

Authors:  Marguerite V Evans-Galea; Louise A Corben; Justin Hasell; Charles A Galea; Michael C Fahey; Desirée du Sart; Martin B Delatycki
Journal:  Neurogenetics       Date:  2011-08-10       Impact factor: 2.660

2.  Auditory function in individuals within Leber's hereditary optic neuropathy pedigrees.

Authors:  Gary Rance; Lisa S Kearns; Johanna Tan; Anthony Gravina; Lisa Rosenfeld; Lauren Henley; Peter Carew; Kelley Graydon; Fleur O'Hare; David A Mackey
Journal:  J Neurol       Date:  2011-09-02       Impact factor: 4.849

3.  Auditory pathway changes mirror overall disease progress in individuals with Friedreich ataxia.

Authors:  Gary Rance; Louise A Corben; Martin B Delatycki
Journal:  J Neurol       Date:  2012-09-30       Impact factor: 4.849

Review 4.  Clinical features of Friedreich ataxia.

Authors:  Martin B Delatycki; Louise A Corben
Journal:  J Child Neurol       Date:  2012-06-29       Impact factor: 1.987

5.  Auditory processing deficits in children with Friedreich ataxia.

Authors:  Gary Rance; Louise Corben; Martin Delatycki
Journal:  J Child Neurol       Date:  2012-06-29       Impact factor: 1.987

Review 6.  Friedreich ataxia: clinical features and new developments.

Authors:  Medina Keita; Kellie McIntyre; Layne N Rodden; Kim Schadt; David R Lynch
Journal:  Neurodegener Dis Manag       Date:  2022-06-29

7.  Auditory function in Pelizaeus-Merzbacher disease.

Authors:  Thierry Morlet; Kyoko Nagao; S Charles Bean; Sara E Mora; Sarah E Hopkins; Grace M Hobson
Journal:  J Neurol       Date:  2018-05-03       Impact factor: 4.849

8.  Progress in understanding Friedreich's ataxia using human induced pluripotent stem cells.

Authors:  Anna M Schreiber; Julia O Misiorek; Jill S Napierala; Marek Napierala
Journal:  Expert Opin Orphan Drugs       Date:  2019-01-09       Impact factor: 0.694

Review 9.  Consensus clinical management guidelines for Friedreich ataxia.

Authors:  Louise A Corben; David Lynch; Massimo Pandolfo; Jörg B Schulz; Martin B Delatycki
Journal:  Orphanet J Rare Dis       Date:  2014-11-30       Impact factor: 4.123

10.  Friedreich Ataxia and nephrotic syndrome: a series of two patients.

Authors:  Julianna E Shinnick; Charles J Isaacs; Sharon Vivaldi; Kimberly Schadt; David R Lynch
Journal:  BMC Neurol       Date:  2016-01-12       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.